Rossari Biotech Limited Announces Inter-Se Transfer of Shares Among Promoters

Rossari Biotech Limited, listed on the National Stock Exchange of India, has issued an announcement regarding the inter-se transfer of shares among promoters. According to the company's letter dated August 20, 2025, the transfer of 88,00,000 shares was made on August 28, 2025, among Sunil Srinivasan Chari, Yash Sunil Chari, Jyotishna Sunil Chari, and Chari Family Trust. This transfer is exempt from the SEBI SAST Regulations under Regulation 10(1)(a)(ii). The aggregate holding of the promoter and promoter group remains unchanged.

Key Takeaways:

  • The company has received an intimation from promoters regarding the acquisition of equity shares through an off-market inter-se transfer.
  • The transfer of 88,00,000 shares was made on August 28, 2025, among Sunil Srinivasan Chari, Yash Sunil Chari, Jyotishna Sunil Chari, and Chari Family Trust.
  • The proposed transaction falls within the exemption under Regulation 10(1)(a)(ii) of SEBI SAST Regulations.
  • The aggregate holding of the promoter and promoter group remains unchanged.
  • The company has enclosed the necessary disclosures under Regulation 10(6) of SEBI SAST Regulations for information and records.
  • Sunil Srinivasan Chari is the promoter, and Yash Sunil Chari and Jyotishna Sunil Chari are part of the promoter group.
  • Chari Family Trust is another entity involved in the transfer.

Statistics:

  • 88,00,000 shares were transferred among promoters.
  • The shares were transferred on August 28, 2025.
  • The aggregate holding of the promoter and promoter group stands at 15.89% of the total holding.
  • The securities are listed on the National Stock Exchange of India.

Sources:

  • National Stock Exchange of India Limited
  • Securities and Exchange Board of India (SEBI)